Tata pharma and healthcare fund direct growth
WebMar 22, 2024 · Tata India Pharma & HealthCare Fund Regular-Growth Fund Key Highlights 1. Current NAV: The Current Net Asset Value of the Tata India Pharma & HealthCare Fund - Regular Plan as of Mar 22, 2024 is Rs 15.59 for Growth option of its Regular plan. 2. Returns: Its trailing returns over different time periods are: -9.45% (1yr), 19.89% (3yr), 13.04% (5yr) … WebMar 23, 2024 · Tata India Pharma & HealthCare Fund Direct-Growth is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on Invalid date and is …
Tata pharma and healthcare fund direct growth
Did you know?
WebApr 6, 2024 · Tata India Pharma & HealthCare Fund Regular Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding … WebApr 13, 2024 · Tata India Pharma & Healthcare Fund Direct Growth: Category : Sector - Healthcare Distribution Type : Growth Structure : Open Ended: Latest NAV : 18.3779: NAV Date : Apr 13, 2024: Tata India Pharma & Healthcare Fund …
WebTata India Pharma & Healthcare Fund Direct Growth risk and rating. Home; Portfolio; Mutual Funds. Funds Home NEW; Analyst Ratings NEW; Factsheets NEW; Fund News NEW; … WebApr 11, 2024 · Tata India Pharma & Healthcare Fund Direct Growth - Latest NAV ₹18.4528. Detailed analysis & complete track record of Tata India Pharma & Healthcare Fund Direct …
WebPortfolio for Tata India Pharma & Healthcare Fund Direct Growth along with asset allocation, stock style, sector and region exposure, ... INVESCO ITI JM KOTAK LIC LNT … WebApr 12, 2024 · This scheme was launched on Invalid date and is currently managed by its fund managers V Srivatsa and Kamal Gada. It has an AUM of ₹ 655.16 Crores and the latest NAV decalared is ₹ 160.520 as on 08 Apr 2024 at 5:04 am. UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is -7.61%, in last 3 years is 83.62% and …
WebCheck portfolio overview & analysis for Tata India Pharma And Healthcare Fund Direct Growth. Know more about asset allocation, sector allocation, list of stocks bought/sold, historical data, and more.
WebMar 1, 2024 · The Tata India Pharma & Healthcare Fund Direct Growth has an AUM of 503.58 crores & has delivered CAGR of 14.31% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 1.00%. halton view residentsWebApr 13, 2024 · Invest in high-rated bonds from as low as Rs. 10,000 Find & Invest in bonds issued by top corporates, PSU Banks, NBFCs, and much more. Invest as low as 10,000 and earn better returns than FD ... burn blister on bottom of foot and treatmentWebGet the latest Tata India Pharma & Healthcare Fund Direct Growth (TATA_INDI_PHAR_WGSTAL) real-time quote, historical performance, charts, and other … burn blister infectionWebGet complete details on NAV, performance, scheme objective, regular and direct plan AUMs, Returns, Minimum SIP investment amount, benchmark, fund manager performance, Tata … halton view post office opening timesWebGet the latest Tata India Pharma & Healthcare Fund Direct Growth (TATA_INDI_PHAR_WGSTAL) real-time quote, historical performance, charts, and other financial information to help you make more ... halton view care home widnesWebJan 6, 2024 · The Net Asset Value is the per share market value of a mutual fund scheme. It is obtained by dividing the difference between the firm's total assets and liabilities by the number of outstanding units in the fund. Tata India Pharma & Healthcare Fund Direct Growth NAV calculation: NAV: (Assets - Liabilities)/ Total Number of Outstanding Units burn blister in mouthWebGet detailed Portfolio analysis for Tata India Pharma & Heathcare Fund. Check detailed stocks and debt portfolio holding, changes in portfolio, list of stocks bought/sold, risk … halton village butchers